Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03706027 · ClinicalTrials.gov registry record · NA

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

A NA study of Lung Cancer, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03706027: Recruiting NA study of Lung Cancer, sponsored by University of Rochester.

NCT03706027 is a NA study of Lung Cancer that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03706027, a NA study of Lung Cancer, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.

Conditions Studied

Lung Cancer

Interventions

  • DEVICE radiation therapy-3 fractions
  • DEVICE Radiation therapy-5 fractions

Study Locations (1)

New York

  • James P. Wilmot Cancer Center at University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-12-15
Est. Completion 2026-11-15
Phase NA

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03706027

The ClinicalTrials.gov registry entry for NCT03706027 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which radiation therapy-3 fractions is the first listed.

NCT03706027 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03706027 about?

NCT03706027 is a clinical study titled "Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer". This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatm...

What is the current status of trial NCT03706027?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2018-12-15. Estimated completion is 2026-11-15.

What conditions does trial NCT03706027 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03706027?

The interventions under investigation include: radiation therapy-3 fractions (DEVICE), Radiation therapy-5 fractions (DEVICE).

Who is sponsoring clinical trial NCT03706027?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03706027 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.